Treatment of COVID-19: implications for antimicrobial resistance in Africa.
Pan Afr Med J
; 35(Suppl 2): 119, 2020.
Article
in English
| MEDLINE | ID: covidwho-962486
ABSTRACT
There is currently no approved pharmaceutical product for the treatment of COVID-19. However, antibiotics are currently being used for the management of COVID-19 patients in many settings either treat to co-infections or for the treatment of COVID-19 itself. In this commentary, we highlight that the increased rates of antimicrobial prescribing for COVID-19 patients could further worsen the burden of antimicrobial resistance (AMR). We also highlight that though AMR is a global threat, Africa tends to suffer most from the consequences. We, therefore, call on African countries not to lose sight of the possible implications of the treatment of COVID-19 on AMR and a need to redouble efforts towards the fight against AMR while dealing with the pandemic.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Drug Resistance, Bacterial
/
SARS-CoV-2
/
COVID-19 Drug Treatment
/
Anti-Bacterial Agents
Limits:
Humans
Country/Region as subject:
Africa
Language:
English
Journal:
Pan Afr Med J
Year:
2020
Document Type:
Article
Affiliation country:
Pamj.supp.2020.35.23713
Similar
MEDLINE
...
LILACS
LIS